BRPI0815092A2 - Moduladores duais de receptores 5-ht2a e d3 - Google Patents

Moduladores duais de receptores 5-ht2a e d3

Info

Publication number
BRPI0815092A2
BRPI0815092A2 BRPI0815092-3A2A BRPI0815092A BRPI0815092A2 BR PI0815092 A2 BRPI0815092 A2 BR PI0815092A2 BR PI0815092 A BRPI0815092 A BR PI0815092A BR PI0815092 A2 BRPI0815092 A2 BR PI0815092A2
Authority
BR
Brazil
Prior art keywords
ht2a
dual
receiver modulators
modulators
receiver
Prior art date
Application number
BRPI0815092-3A2A
Other languages
English (en)
Inventor
Luca Gobbi
Georg Jaeshke
Olivier Roche
Rosa Maria Rodrigues Sarmiento
Lucinda Steward
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0815092A2 publication Critical patent/BRPI0815092A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0815092-3A2A 2007-07-26 2008-07-17 Moduladores duais de receptores 5-ht2a e d3 BRPI0815092A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113252 2007-07-26
PCT/EP2008/059356 WO2009013212A2 (en) 2007-07-26 2008-07-17 Dual modulators of 5-ht2a and d3 receptors

Publications (1)

Publication Number Publication Date
BRPI0815092A2 true BRPI0815092A2 (pt) 2015-02-03

Family

ID=40281888

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815092-3A2A BRPI0815092A2 (pt) 2007-07-26 2008-07-17 Moduladores duais de receptores 5-ht2a e d3

Country Status (16)

Country Link
US (4) US20090029977A1 (pt)
EP (1) EP2183245B1 (pt)
JP (1) JP5502733B2 (pt)
KR (1) KR101169518B1 (pt)
CN (1) CN101778844B (pt)
AR (1) AR067662A1 (pt)
AU (1) AU2008280187B2 (pt)
BR (1) BRPI0815092A2 (pt)
CA (1) CA2694009A1 (pt)
CL (1) CL2008002162A1 (pt)
ES (1) ES2498673T3 (pt)
PE (1) PE20090892A1 (pt)
RU (1) RU2480466C2 (pt)
TW (1) TWI363623B (pt)
WO (1) WO2009013212A2 (pt)
ZA (1) ZA201000354B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399447T3 (es) * 2006-02-17 2013-04-01 F. Hoffmann-La Roche Ag Derivados benzoil-piperidina como moduladores de 5HT2/D3
JP5367824B2 (ja) * 2008-09-22 2013-12-11 エフ．ホフマン−ラ ロシュ アーゲー ピペラジンｄ３及び５−ｈｔ２ａ受容体調節薬
BRPI0919342A2 (pt) 2008-09-23 2015-12-29 Hoffmann La Roche derivados do isoxazol [4,5] piridin-3-il-piperazina, seu processo de preparação, seu medicamento e seu uso
US8470828B2 (en) * 2010-07-06 2013-06-25 Hoffmann-La Roche Inc. Anellated pyridine compounds
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8722683B2 (en) * 2011-02-17 2014-05-13 Hoffmann La-Roche Inc. Benzodioxole piperazine compounds
US8598357B2 (en) * 2011-03-03 2013-12-03 Hoffmann-La Roche Inc. Benzodioxole piperidine compounds
US8921397B2 (en) * 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
CN105367565B (zh) * 2014-08-20 2018-10-02 上海医药工业研究院 哌嗪(啶)环己基衍生物及其治疗精神神经疾病的应用
CN106518841B (zh) * 2015-09-15 2019-03-05 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
WO2017045599A1 (zh) * 2015-09-15 2017-03-23 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
WO2018021447A1 (ja) 2016-07-28 2018-02-01 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物
US11447484B2 (en) 2018-01-26 2022-09-20 Shionogi & Co., Ltd. Cyclic compound having dopamine D3 receptor antagonistic effect
CA3089498A1 (en) 2018-01-26 2019-08-01 Shionogi & Co., Ltd. Condensed ring compounds having dopamine d3 receptor antagonistic effect
MX2022004473A (es) 2019-10-29 2022-05-06 Shanghai Hansoh Biomedical Co Ltd Modificador de un derivado de anillo de cuatro miembros, metodo de preparacion y aplicacion del mismo.
US12459931B2 (en) 2019-11-05 2025-11-04 Shanghai Hansoh Biomedical Co., Ltd. Benzothiophene derivative regulator, preparation method therefor and use thereof
JP7693709B2 (ja) 2020-04-26 2025-06-17 ジャンスー・エンファ・ファーマシューティカル・カンパニー・リミテッド １，５－ジヒドロ－２，４－ベンゾジアゼピン－３－オン誘導体及びその使用
AU2022266937A1 (en) 2021-04-28 2023-10-19 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DK60693D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
PT1015446E (pt) 1997-02-07 2003-08-29 Aventis Pharma Inc Derivados de (4-piperidinil)-1h-2-benzopirano uteis como agentes antipsicoticos
JP4627882B2 (ja) * 1998-02-09 2011-02-09 デユフアー・インターナシヨナル・リサーチ・ベー・ブイ Ｄ４−アンタゴニスト活性を有するベンズイソキサゾール誘導体
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
JP4497815B2 (ja) 2001-02-16 2010-07-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規な複素環式アミド誘導体およびドーパミンｄ３受容体リガンドとしてのその使用
GB0117950D0 (en) 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
ATE412638T1 (de) 2001-02-16 2008-11-15 Aventis Pharma Inc Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden
ES2399447T3 (es) * 2006-02-17 2013-04-01 F. Hoffmann-La Roche Ag Derivados benzoil-piperidina como moduladores de 5HT2/D3
JP5087631B2 (ja) * 2006-10-31 2012-12-05 エフ．ホフマン−ラ ロシュ アーゲー ５−ｈｔ２ａ及びｄ３受容体のデュアルモジュレーターのエーテル誘導体
JP5296073B2 (ja) * 2007-08-09 2013-09-25 エフ．ホフマン−ラ ロシュ アーゲー ５−ｈｔ２ａ及びｄ３受容体のデュアルモジュレーターとしてのベンゾイル−ピペリジン誘導体
JP5367824B2 (ja) * 2008-09-22 2013-12-11 エフ．ホフマン−ラ ロシュ アーゲー ピペラジンｄ３及び５−ｈｔ２ａ受容体調節薬
PL2420558T3 (pl) * 2010-08-17 2017-12-29 The Procter And Gamble Company Stabilne, trwałe detergenty do ręcznego zmywania naczyń
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds

Also Published As

Publication number Publication date
RU2480466C2 (ru) 2013-04-27
US20090029977A1 (en) 2009-01-29
AU2008280187B2 (en) 2013-05-16
ZA201000354B (en) 2010-10-27
WO2009013212A3 (en) 2009-06-11
US20140350051A1 (en) 2014-11-27
CN101778844A (zh) 2010-07-14
TWI363623B (en) 2012-05-11
US20130165432A1 (en) 2013-06-27
US8829029B2 (en) 2014-09-09
PE20090892A1 (es) 2009-07-13
KR20100036384A (ko) 2010-04-07
WO2009013212A2 (en) 2009-01-29
EP2183245B1 (en) 2014-07-09
CN101778844B (zh) 2013-01-02
KR101169518B1 (ko) 2012-07-27
JP2010534632A (ja) 2010-11-11
AR067662A1 (es) 2009-10-21
ES2498673T3 (es) 2014-09-25
CA2694009A1 (en) 2009-01-29
RU2010104631A (ru) 2011-09-10
US20120040972A1 (en) 2012-02-16
JP5502733B2 (ja) 2014-05-28
CL2008002162A1 (es) 2009-05-29
EP2183245A2 (en) 2010-05-12
AU2008280187A1 (en) 2009-01-29
TW200911236A (en) 2009-03-16

Similar Documents

Publication Publication Date Title
BRPI0815092A2 (pt) Moduladores duais de receptores 5-ht2a e d3
CR10930A (es) Moduladores receptores nicotinicos de acetilcolina
EP2173040A4 (en) SINGLE PORT SIGNAL BOOSTER
EP2051523A4 (en) RECEIVER
BRPI0818380A2 (pt) Combinação de herbicida-protetor
EP2333393A4 (en) Joint unit
BRPI0903496A2 (pt) Dispositivos de transmissão e de recepção.
EP2033391A4 (en) AltBOC RECEIVER
BRPI0921327A2 (pt) Combinação de herbicida-protetor
GB2452361B (en) Optical time domain refectometry
BRPI0820978A2 (pt) Comunicação de conteúdo de alteração visual
EP3270564C0 (en) Distributed security provisioning
EP2124523A4 (en) BREEDING LINE P2428-5006090
BRPI0918949A2 (pt) moduladores de receptores de 5-ht2a e piperazina d3
BRPI0908821A2 (pt) Transmissão hidrostática com divisão de potência
EP2192831A4 (en) Teat cup lining
ITMI20072422A1 (it) Ricevitore ottico
EP2153565A4 (en) TRANSFER MODE SELECTION
EP2116533A4 (en) Glucokinase AKTIVATOR
BRPI0921058A2 (pt) éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos
BRPI0811115A2 (pt) Compostos de heteroarilamida pirimidona
EP2304494A4 (en) BACKLIGHT UNIT
EP2309690A4 (en) FSK RECEIVER
BRPI0922728A2 (pt) combinação de herbicida-antídoto
BRPI0810195A2 (pt) Moduladores de gpbar1

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)